Research and laboratory use only. Not for human consumption.
NAD+
NAD+ is an essential cellular coenzyme present throughout biology. It plays central roles in oxidation-reduction reactions, mitochondrial energy metabolism, ATP production, DNA repair, sirtuin signalling, cellular stress responses and regulation of metabolic homeostasis.
What is NAD+?
NAD+ stands for nicotinamide adenine dinucleotide . It is one of the most fundamental metabolic cofactors found in living cells.
NAD+ participates in hundreds of enzymatic reactions and is particularly important for transferring electrons during cellular energy metabolism.
During these reactions NAD+ can accept electrons and hydrogen to become NADH. NADH can subsequently donate those electrons, regenerating NAD+.
This continuous NAD+/NADH cycle is central to glycolysis, the tricarboxylic acid cycle and mitochondrial oxidative phosphorylation.
NAD+ also functions as a substrate for enzymes involved in DNA repair, chromatin regulation, stress responses, calcium signalling and cellular ageing.
Interest in NAD+ has grown considerably because disturbances in NAD metabolism have been associated with metabolic disease, mitochondrial dysfunction, inflammation and several aspects of ageing biology.
NAD+ is not a peptide
NAD+ is included within the ASA Research information centre because of its importance to mitochondrial and cellular research, but chemically it belongs to a completely different class from peptides such as MOTS-c or BPC-157.
Chains of amino acids
Peptides are molecules composed of amino acids joined together through peptide bonds.
Examples include MOTS-c, BPC-157, Ipamorelin and GHK.
Dinucleotide coenzyme
NAD+ consists of two nucleotide components connected through phosphate groups.
It functions principally as a redox cofactor and enzyme substrate rather than as an amino-acid signalling peptide.
What does NAD+ mean?
NAD is an abbreviation for nicotinamide adenine dinucleotide .
The molecule contains two nucleotides: one built around an adenine group and another containing nicotinamide.
The superscript + identifies the oxidized form of the molecule.
When NAD+ accepts electrons during a biochemical reaction, it is reduced to NADH.
The ability to cycle repeatedly between these states is what makes NAD such an important cellular redox carrier.
Molecular architecture
NAD+ contains two ribonucleotide units joined through a pyrophosphate bridge.
The NAD+/NADH cycle
One of NAD's most important roles is transferring electrons between metabolic reactions.
NAD+ acts as an oxidizing agent by accepting electrons from another molecule.
In doing so, NAD+ becomes its reduced form, NADH.
NADH subsequently donates high-energy electrons to other biochemical pathways, including the mitochondrial respiratory chain.
Oxidation of NADH regenerates NAD+, allowing the molecule to cycle continuously.
The ratio between NAD+ and NADH is therefore an important indicator of the cellular redox environment and strongly influences metabolism.
Why is NAD+ so important?
NAD+ connects energy production with cellular signalling, genome maintenance and responses to biological stress.
Cellular Energy
NAD+/NADH redox chemistry is essential to glycolysis, the TCA cycle and oxidative phosphorylation.
Mitochondrial Function
NADH provides electrons used by the respiratory chain to support ATP production.
DNA Repair
PARP enzymes consume NAD+ during responses to DNA damage and genome maintenance.
Ageing Biology
Changes in NAD metabolism have been linked experimentally to several hallmarks of ageing.
NAD+ is more than an energy molecule
NAD+ participates both as a reversible redox cofactor and as a consumable substrate for multiple signalling enzymes.
Redox Metabolism
NAD+ accepts electrons during nutrient oxidation and helps transfer reducing equivalents toward ATP-producing pathways.
Genome Maintenance
NAD+ is consumed by PARP enzymes during DNA-damage responses and repair-related signalling.
Sirtuin Activity
Sirtuins require NAD+ as a cosubstrate and regulate proteins involved in metabolism, stress resistance and gene expression.
Calcium Signalling
NAD-derived signalling metabolites participate in intracellular calcium regulation and cellular communication.
Sirtuins, PARPs and CD38
Some enzymes use NAD+ as a substrate and chemically consume it rather than merely cycling it between NAD+ and NADH.
Sirtuins
The seven mammalian sirtuins are NAD+-dependent enzymes involved in deacylation and related reactions. They connect cellular NAD availability with metabolism, stress responses and gene regulation.
PARPs
Poly(ADP-ribose) polymerases consume NAD+ during ADP-ribosylation reactions, particularly in response to DNA damage. Excessive activation can substantially reduce cellular NAD+ stores.
CD38
CD38 is a major NAD-consuming enzyme involved in immune and calcium signalling. Increased CD38 activity has been proposed as one contributor to altered NAD metabolism with ageing.
Cells continually regenerate NAD+
NAD+ is not simply stored indefinitely. Cells continually synthesize and recycle the molecule through several biochemical pathways.
In many mammalian tissues, the nicotinamide salvage pathway is an important source of NAD+.
Nicotinamide produced when NAD-consuming enzymes operate can be recycled through NAMPT and NMNAT enzymes back into NAD+.
NAD+ can also be generated from dietary vitamin B3 forms and from tryptophan through longer biosynthetic pathways.
This network explains why much clinical NAD research has investigated precursor molecules such as nicotinamide riboside and NMN rather than administering NAD+ itself.
Does NAD+ decline with age?
Animal research strongly supports age-related changes in NAD metabolism. Human evidence is more complicated and appears to vary by tissue, population and measurement method.
Strong biological rationale
In many animal models, ageing is accompanied by reduced NAD availability, altered NAD biosynthesis and increased NAD consumption.
Restoring NAD through genetic, nutritional or pharmacological approaches has improved metabolic and functional endpoints in numerous rodent experiments.
Less consistent than often claimed
Human studies do provide evidence of age-related NAD changes in some tissues, but the pattern is not uniformly demonstrated across every organ or cohort.
Recent reviews emphasize that human tissue-level NAD dynamics remain incompletely mapped and should not simply be inferred from rodent ageing studies.
What has actually been demonstrated in humans?
Human trials show that several NAD+ precursors can alter NAD-related biomarkers, but effects on health outcomes remain inconsistent.
Human NAD research is substantially more developed for nicotinamide riboside (NR) and nicotinamide mononucleotide (NMN) than for direct administration of NAD+.
Controlled trials generally show that these precursor strategies can increase NAD-related metabolites in blood or cellular compartments.
This demonstrates biochemical target engagement, but improvements in clinically meaningful outcomes have been inconsistent.
Trials have investigated metabolism, vascular function, muscle physiology, neurological disease, inflammatory states and measures associated with ageing.
Results vary considerably between populations and endpoints, and many studies remain relatively small or short.
A 2026 systematic review of human and animal intervention studies concluded that NAD+ augmentation has clear biological activity, but clinical effectiveness for anti-ageing and wellness outcomes remains inconclusive.
NAD+ is not the same intervention as NR or NMN
Studies involving one NAD-related compound should not automatically be presented as evidence for another.
NAD+
NAD+ itself is the final cellular coenzyme. Direct parenteral NAD+ administration is promoted in some wellness settings, but clinical outcomes evidence remains extremely limited.
NMN
Nicotinamide mononucleotide is an intermediate in NAD+ biosynthesis. Multiple human studies have examined oral NMN and its effects on NAD biomarkers and metabolic endpoints.
NR
Nicotinamide riboside is a vitamin B3 derivative capable of entering NAD+ biosynthetic pathways. It has been evaluated in numerous randomized human studies.
A clinical result produced by oral NR or NMN does not demonstrate that intravenous, intramuscular or other direct NAD+ administration produces the same exposure, tissue effects, safety profile or clinical outcome.
How strong is the evidence?
NAD+ biology itself is exceptionally well established. The uncertainty lies primarily in translating NAD-boosting strategies into proven human therapeutic outcomes.
Fundamental Biology
NAD+/NADH redox chemistry and its role in cellular metabolism are foundational biochemistry.
Preclinical Ageing Research
Extensive animal studies support roles in metabolism, mitochondrial function, inflammation and age-related biology.
Human Precursor Trials
NR and NMN can alter NAD-related biomarkers in humans, although clinical outcomes are variable.
Direct NAD+ Wellness Therapy
Robust randomized clinical evidence for intravenous NAD+ as an anti-ageing or wellness treatment is lacking.
What don't we know?
Factors affecting NAD+ stability
NAD+ is a chemically reactive dinucleotide whose stability depends on formulation, pH, temperature, solvent and storage conditions. Compound-specific analytical information should therefore be used for laboratory material.
Temperature
Elevated temperature can accelerate degradation of NAD-containing laboratory preparations.
pH
Acidic or alkaline conditions can affect nucleotide stability and degradation kinetics.
Light & Environment
Environmental exposure can influence chemical integrity depending on the formulation and storage container.
Material Specification
Salt form, purity, hydration state, concentration and formulation should be identified in analytical documentation.
Essential endogenous coenzyme — therapeutic NAD+ augmentation remains an active research field
NAD+ is an essential biological molecule with established roles in cellular redox metabolism, mitochondrial energy production, DNA repair and intracellular signalling.
Strategies designed to alter NAD+ metabolism are being actively investigated in humans, particularly through nicotinamide riboside, nicotinamide mononucleotide and other precursor approaches.
Human studies consistently show that some precursor strategies can alter NAD-related biomarkers, but evidence for broad anti-ageing, metabolic, neurological or wellness benefits remains inconsistent.
Direct intravenous NAD+ is offered in some commercial wellness settings, but current systematic reviews identify a major lack of randomized clinical outcomes evidence supporting intravenous NAD+ itself for anti-ageing or general wellness.
ASA Research Labs provides this information for scientific and educational purposes only. Nothing on this page should be interpreted as medical advice, administration guidance or a recommendation for human use.
Selected scientific references
Selected literature covering NAD metabolism, ageing biology, NAD-consuming enzymes, mitochondrial function, precursor trials and current clinical evidence.
Scientific research information only
This profile is provided for scientific and educational information. NAD+ is an essential endogenous cellular coenzyme, but discussion of NAD metabolism, ageing, mitochondrial function, sirtuins, DNA repair, NR, NMN or direct NAD+ administration does not establish that exogenous NAD+ prevents ageing or treats metabolic, neurological, cardiovascular or other human diseases. Evidence from NAD+ precursor studies should not be automatically extrapolated to direct NAD+ administration. This page does not provide instructions for administration, dosing or human use.